ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 406 filers reported holding ENCOMPASS HEALTH CORP in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,051 | -0.8% | 15,653 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $1,060 | +25.1% | 15,653 | 0.0% | 0.01% | +20.0% |
| Q1 2023 | $847 | +49.9% | 15,653 | +65.6% | 0.01% | +25.0% |
| Q4 2022 | $565 | -99.9% | 9,453 | 0.0% | 0.00% | +33.3% |
| Q3 2022 | $428,000 | -19.2% | 9,453 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $530,000 | -53.3% | 9,453 | -40.7% | 0.00% | -50.0% |
| Q1 2022 | $1,134,000 | +8.9% | 15,953 | 0.0% | 0.01% | +20.0% |
| Q4 2021 | $1,041,000 | -13.0% | 15,953 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $1,197,000 | -3.9% | 15,953 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $1,245,000 | -14.4% | 15,953 | -10.1% | 0.01% | -25.0% |
| Q1 2021 | $1,454,000 | -12.3% | 17,753 | -11.5% | 0.01% | -20.0% |
| Q4 2020 | $1,658,000 | +27.2% | 20,053 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $1,303,000 | -47.5% | 20,053 | -50.0% | 0.01% | -9.1% |
| Q2 2020 | $2,484,000 | – | 40,106 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |